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Objective: The prevalence of maternal overweight and obesity is high and the impact is far 
reaching. Recent studies suggest that fetal exposure to maternal obesity is related to poor 
neurodevelopmental outcomes in childhood. However, limited data have been collected on the 
developing fetus. Studies also suggest that the adverse effect was mediated through insulin 
resistance (IR) and inflammation. We investigated if maternal pre-pregnancy BMI, gestational 
weight gain (GWG) and newborn adiposity, were associated with fetal autonomic nervous 
development as indicated by fetal heart rate variability (HRV) and newborn behavior. We also 
investigated if maternal IR and inflammation were associated with fetal HRV.   
 
Material and methods: A total of 48 mother-offspring pairs were analyzed. Short-term (SD1) 
and overall (SD2) fetal HRV were measured at 32 and 36 weeks of pregnancy using fetal 
magnetocardiogram. Maternal plasma levels of glucose, insulin, and inflammatory cytokines 
(TNF-α and IL-6) were analyzed from maternal peripheral blood collected at 36 weeks of 
pregnancy. Newborn body composition was measured using air-displacement plethysmography 
(PeaPod®). Multiple linear regression models predicted fetal HRV measures (SD1 and SD2 at 36 
week, and SD1 and SD2 change between 32 and 36 week) and NBAS clusters from maternal and 
newborn factors. Infant gender and pre-pregnancy BMI were included as confounders.  
 
Results: In the adjusted regression model, greater GWG was associated with greater SD1 
(β=0.442; R2=0.19; p=0.003) and with SD1 change (β =0.511; R2=0.27; p=0.007). Lower 
newborn %fat was associated with greater SD2 change, but the association was diminished in the 
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adjusted model (β=-0.426; R2=0.17; p=0.055). No correlation was found between any of NBAS 
cluster scores and maternal or infant predictors, and between fetal HRV and maternal IR and 
blood inflammatory markers.  
 
Conclusions: Greater GWG was associated with better fetal autonomic nervous development, 
while greater newborn %fat was associated with poorer fetal autonomic nervous development. 
Further studies are needed to elucidate the impact of maternal and fetal/newborn adiposity on 
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Maternal obesity and excessive gestational weight gain (GWG) are now considered major 
public health concerns due to obesity associated health outcomes and a high prevalence of 
occurrence. A 2011 Pregnancy Nutrition Surveillance System report stated the prevalence of 
maternal overweight or obesity (pre-pregnancy body mass index (BMI) > 25 kg/m2) in the US is 
53.6%, and 48% of women gain greater than ideal weight during pregnancy [1]. Both maternal 
pre-pregnancy BMI and GWG are positively correlated with the offspring’s adiposity and 
adverse cardiovascular risk factors at birth and later life [2-10].  Despite convincing evidence 
that the intrauterine environment influences growth and development of the offspring, it is not 
fully understood how obesity and excessive GWG influence offspring health.    
Independent of pregnancy, obesity is associated with poor autonomic nervous system 
(ANS) function [11-14]. The ANS plays an important role in the pathophysiology of various 
diseases, including hypertension [15], atherosclerosis [16], and type-2 diabetes mellitus [17, 18].  
Studies suggest that ANS dysfunction is associated with body fat mass (FM) and contributes to 
the development of insulin resistance (IR) and diabetes [13, 14, 17, 19-21]. Heart rate variability 
(HRV) is an index of ANS development and function. In fetuses, higher HRV is considered an 
indicator of a more mature ANS [22].  In healthy, non-pregnant adults and in those with 
cardiovascular disease, a decrease in HRV is associated with higher levels of inflammatory 
markers [16, 23-26].    
A previous study links fetal HRV to postnatal developmental outcomes [27]. A higher 
fetal HRV is related to a higher HRV at one month of age, suggesting that the ANS is 
programmed during gestation. Because ANS dysfunction is associated with various diseases, 
exposure to events during intrauterine development of the ANS may program offspring 
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susceptibility to disease development later in life. Therefore, fetal HRV could predict later 
disease risk.    
ANS function in neonates and young infants is reflected by self-regulation of behavior 
and assessed in part by the Neonatal Behavioral Assessment Scale (NBAS) [28]. While many 
studies confirm the role of the ANS in the pathophysiology of diseases, less is known about the 
interaction between the intrauterine environment and fetal ANS development. Human 
observational studies have shown that pre-pregnancy obesity is associated with IR, impaired 
metabolism, and inflammation in both the mother and fetus which results in greater infant 
adiposity. This association is stronger in women who gain excessive gestational weight [29, 30]. 
However, the effects of these factors on fetal ANS development have yet to be investigated.     
Evidence from animal studies show that maternal adiposity and higher placental glucose 
transport to the fetus is associated with impaired offspring ANS development [31, 32]. 
Additionally, a recent study indicated that increased GWG is associated with decreased fetal 
HRV [33]. Although the study was not designed to investigate the association between GWG 
and fetal HRV, the finding supports previous animal studies that suggest an association between 
maternal adiposity and offspring ANS development [31]. We speculate that greater neonatal 
adiposity and maternal pre-pregnancy obesity and/or excessive GWG may induce alteration in 
ANS function. The relationship could occur through a direct mechanism or indirectly by 
activation of placental inflammatory pathway or fetal metabolic changes induced by maternal 
adiposity may alter the fetal ANS function independent from fetal adiposity.             
 Understanding how maternal conditions relate to fetal ANS development will help to 
identify the pathways that can be targeted for nutrition or lifestyle intervention. Therefore, the 
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study aims are to investigate the relationships between maternal adiposity, maternal IR and 
inflammation, and infant adiposity on ANS development of the fetus and neonates.   
 
1.2. Specific aims 
The general aim of this study is to analyze the relationships of intra-uterine factors during 
pregnancy and ANS and newborn behavior of the offspring.  Intra-uterine factors include 
maternal adiposity (pre-pregnancy BMI and GWG), newborn adiposity (newborn FM), maternal 
inflammation and maternal IR.  ANS and behavior of the offspring include non-linear fetal HRV 
measures (SD1 and SD2) at 36 weeks of gestational age, the change in the fetal HRV measures 
(SD1 at 36 weeks – SD1 at 32 weeks, and SD2 at 36 weeks – SD2 at 32 weeks) and NBAS 
score.  In specific, the study aims are as follow:     
 
Aim 1. To determine the relationships between maternal adiposity and fetal HRV and newborn 
behavior, and between neonatal adiposity and fetal autonomic development and newborn behavior. 
Hypothesis 1.1: Pre-pregnancy BMI is negatively associated with the fetal HRV. 
Hypothesis 1.2: GWG is negatively associated with the fetal HRV. 
Hypothesis 1.3: Pre-pregnancy BMI is negatively associated with fetal HRV change. 
Hypothesis 1.4: GWG is negatively associated with the change of the fetal HRV. 
Hypothesis 1.5: Pre-pregnancy BMI is negatively associated with NBAS score. 
Hypothesis 1.6: GWG is negatively associated with NBAS score. 
Hypothesis 1.7: Newborn FM is negatively associated with the fetal HRV. 
Hypothesis 1.8: Newborn FM is negatively associated with fetal HRV change. 





Aim 2. To determine the relationships between maternal IR and inflammation during pregnancy 
and fetal HRV.  
Hypothesis 2.1: Maternal IR is negatively associated with the fetal HRV.  
Hypothesis 2.2: Maternal IR is negatively associated with the fetal HRV change.  
Hypothesis 2.3: Maternal blood TNF-α is negatively associated with the fetal HRV.  
Hypothesis 2.4: Maternal blood TNF-α is negatively associated with fetal HRV change.    
Hypothesis 2.5: Maternal blood IL-6 is negatively associated with the fetal HRV.  







































2.1. Obesity in pregnancy 
Obesity is a major public health problem in both developed and developing countries. 
Worldwide, it is estimated that more than 1.4 billion people are obese [34]. The risk of obesity 
for cardiovascular disease, type 2 diabetes mellitus, cancer and inflammatory diseases has been 
well documented [35-38].  Because recent studies have suggested that obesity is passed through 
generations, there is an interest in studying the impact of maternal obesity on the offspring. The 
impact of maternal obesity on offspring development may interact with or be independent of the 
effects of excessive GWG. Both conditions are related to increased adiposity in the offspring, as 
well as to increased risk of comorbidities such as type 2 diabetes and cardiovascular diseases.       
 
2.1.1. The problem of pre-pregnancy obesity 
Within the past 30 years, the prevalence of overweight and obesity in women worldwide 
has increased from 29.8% to 38.0% [38, 39]. World Health Organization 2014 statistics indicate 
that more than half of women in 38 out of 136 countries have a BMI greater than recommended 
(> 25 kg/m2) [35]. In the US, about 35.8% of women of reproductive age are obese [40] and 
about one out of five women were obese when they became pregnant [41]. PRAMS data from 20 
states showed that the prevalence of pre-pregnancy obesity has increased by 0.5 percentage 
points per year up to 20.7% in 2009 [42]. The Pregnancy Nutrition Surveillance System 2011 
report stated that the prevalence was 27.6% [1]. Collectively, these statistics highlight the 
developing problem of maternal obesity in the United States and worldwide. In fact, a growing 




2.1.2. Impact of maternal obesity on offspring adiposity at birth 
The trans-generational effect of obesity is demonstrated by studies that show a 
relationship between pre-pregnancy obesity and offspring adiposity at birth. For example, Hull et 
al. [9] measured newborn (2-4 weeks old) body composition using air displacement 
plethysmography (ADP) and compared the body composition of newborns born to obese and 
normal weight mothers. While there was not a difference in birth weight between infants of 
obese and normal weight mothers, FM and percentage body fat (%FM) were higher in newborns 
born to obese mothers compared to newborns born to normal weight mothers.   
Studies suggest the association between maternal pre-pregnancy BMI and offspring 
adiposity differs by gender. In a cross-sectional study involving 599 mother-infant pairs, 
newborn body composition was measured using ADP within 48 hours of birth. Au and 
colleagues [43] found a positive association between maternal pre-pregnancy BMI and neonatal 
%FM. Similar to other studies, males were found to have a lower %FM when compared to 
females [10, 44]. Pereira et al. [45] measured newborn body composition within 72 hours after 
birth using ADP in 100 infants. The study tested the independent effects of maternal diet (total 
energy and macronutrient distribution), maternal pre-pregnancy BMI (dichotomized as <25 
kg/m2 vs. > 25 kg/m2) and GWG on offspring body composition. The multiple regression models 
were run separately for males and females therefore a model including infant gender as a 
dichotomous variable was not completed. They found a positive association between pre-
pregnancy BMI and neonatal FM in males but not females.     
Another study used an advanced imaging technique (MRI) to assess total, regional and 
liver adipose tissue content in 105 infants with a wide variability in age (1 to 28 days old) [46]. A 
positive association was found between maternal pre-pregnancy BMI and infant adiposity. For 
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every one unit increase in maternal pre-pregnancy BMI, they found an increase in neonatal total, 
abdominal and non-abdominal adipose tissue by 8 mL, 2 mL and 5 mL, respectively. Another 
study used less sophisticated methodology to quantify infant adiposity in a larger sample size. 
Tikellis et al. [47] found that independent of birth weight, higher maternal pre-pregnancy BMI 
was associated with greater neonatal sub-scapular skinfold (n=7,945). These data support that a 
relationship exists between maternal pre-pregnancy BMI and offspring adiposity at birth. Data 
has also been published reflecting that this relationship persists into childhood and beyond [48-
51].    
 
2.1.3. Impact of maternal obesity on offspring adiposity beyond infancy 
The influence of maternal pre-pregnancy BMI on infant adiposity at birth extends beyond 
infancy into childhood and adulthood.  Gaillard et al. 2014 [48] reported data from the 
Generation R Study in 4,871 6-year-old children whose body composition was measured using 
DXA. In modeling adjusting for multiple confounders, a positive relationship was found between 
maternal pre-pregnancy BMI and offspring total FM at 6 years old. Similarly, Gale et al. [49] 
assessed body composition using DXA in 216 children at 9 years old. Fat mass and fat-free mass 
indexes (FMI and FFMI, respectively) were calculated (FM (kg)/Height (cm2) and FFM 
(kg)/Height (cm2)). They found a positive relationship between maternal pre-pregnancy BMI and 
offspring FMI at 9 year of age. Kaar and colleagues used MRI to assess total and regional 
adiposity in 313 offspring at 10 years old [50].  They dichotomized maternal pre-pregnancy BMI 
as normal (<25 kg/m2) or overweight/obese (>25 kg/m2). Infants born to overweight/ obese 
women had greater visceral and abdominal subcutaneous adipose tissue compared to offspring 
born to normal weight women. Perng et al. [52] studied 1,090 mother-child pairs from the 
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Project Viva cohort. Body composition was measured from 6-10 years old using DXA. For every 
5 kg/m2 increase in maternal pre-pregnancy BMI, total FM and trunk FM of the offspring 
increased by 0.92 kg and 0.39 kg, respectively. In summary, data confirm that the impact of 
maternal pre-pregnancy weight tracks from birth into childhood.   
Few cohorts have been followed from birth into adulthood with data available from both 
maternal pregnancy and offspring body composition. Reynold et al. 2010 [53] reported data from 
216 participants enrolled in the Motherwell Birth Cohort collected from 1967-68 in the United 
Kingdom. Body fat mass was estimated using skinfolds in the offspring at 30 years old. A 
positive relationship was found between maternal BMI and adult offspring FM. However, 
maternal characteristics from the Motherwell Birth Study are different from today’s pregnant 
population. In the Motherwell Birth Cohort, the average BMI at 17 weeks gestation was 23.3 
kg/m2 and the average GWG was between 9.4-10 kg. The average maternal BMI before 
pregnancy is now 25.0 kg/m2 and the average GWG is 15.7 kg [54]. The older cohort data may 
underestimate the impact of maternal BMI and GWG on FM compared to more recent 
pregnancies.   
 
2.1.4. The problem of excessive GWG 
In response to the growing number of women entering pregnancy overweight or obese 
and in response to data that suggest the effect of GWG varies by pre-pregnancy BMI group, the 
Institute of Medicine (IOM) published updated GWG guidelines in 2009. Updates in the 
guidelines include aligning the BMI categories with WHO BMI categories and a specific range 
of recommend weight gain for obese women (5-9 kg vs. ≥7 kg from 1990 recommendations) 
[55]. Based on the new guidelines, data have shown that the problem of excessive GWG is high. 
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PNSS data from 2011 found that 48% of pregnant women, regardless of pre-pregnancy BMI 
category, gained more than recommended. Similarly, PRAMS 2009-2010 data from 30 states 
found 47.8% of pregnant women gained an excessive amount of body weight [56]. Though the 
overall percentage of women gaining excessive body weight is high, there are disparities for 
excessive GWG between pre-pregnancy BMI groups. Greater percentages of overweight and 
obese women (58.8% and 55.6%, respectively) gain more body weight than recommended when 
compared to normal weight and underweight women (38.6% and 26.2%, respectively) [57]. 
These data highlight the problem of excessive maternal GWG. More concerning are data that 
link excessive maternal GWG and adverse offspring health including greater offspring adiposity 
at birth.   
 
2.1.5. Impact of excessive GWG on offspring adiposity at birth 
Maternal pre-pregnancy obesity is positively associated to higher offspring adiposity at 
birth. Additionally, whether a woman gains an appropriate or excessive amount of gestational 
weight as classified by IOM guidelines has also been shown to impact offspring FM. Crozier et 
al. [58] classified 948 women as gaining an inadequate, adequate or excessive amount of 
gestational weight and then used DXA to measure offspring body composition at birth. They 
found a significant positive association between GWG and neonatal fat mass (β=0.14 (-0.01 – 
0.29), p=0.06). An effect of excessive GWG on offspring FM was also shown in a small study 
including only women with normal pre-pregnancy BMI [59]. Thirty eight women with normal 
pre-pregnancy BMI and their infants were assessed. Newborn FM and %FM were measured 
within 72 hours after birth using ADP. The study found that newborns born to women that 
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gained excessively GWG (n=11) had significantly greater FM than newborns born to women that 
gained an appropriate amount of weight (n=27) (348 vs. 525 g, p=0.009).   
However, other research has found this relationship varies between pre-pregnancy BMI 
groups. Hull et al. [10] studied 306 newborns and categorized mothers by pre-pregnancy BMI 
status (normal, overweight and obese) and by 2009 IOM weight gain classifications (appropriate 
or excessive). Newborn body composition was measured using ADP at 1-2 days after birth. The 
results showed that in the excessive group, newborns born to overweight and obese mothers had 
significantly greater %FM than did those who were born to normal BMI mothers. Most 
interesting were the within group effects. For both offspring born to normal weight or obese 
women, it did not matter whether the mother gained appropriately or excessively. No within 
group difference was found (i.e., appropriate vs. excessive). For example, FM was not different 
between an offspring born to an obese mother that gained appropriately when compared to 
offspring born to an obese mother that gained excessively. However, there was a striking 
difference in FM between the offspring born to overweight women that gained appropriately vs. 
excessively. Offspring born to overweight women that gained excessively had FM similar to 
offspring born to obese women (highest in the sample) and offspring born to overweight women 
that gained appropriately had FM similar to offspring born to normal weight women (lowest in 
the sample). These studies demonstrate a programming effect of maternal GWG on offspring 
adiposity and suggest this effect may vary by pre-pregnancy BMI group. Furthermore, growing 
evidence suggest that the adverse impact of excessive maternal GWG at neonatal period extends 




2.1.6. Impact of excessive GWG on offspring adiposity beyond infancy 
The association between maternal GWG and offspring adiposity in childhood was shown 
in 313 mother-child pairs involved in EPOCH study by Kaar et al. [50]. Measures of offspring 
adiposity (average 10.4 years) included BMI, waist circumference (WC) and visceral adipose 
tissue (VAT) and subcutaneous adipose tissue (SAT) measured by MRI. The interaction between 
maternal pre-pregnancy BMI and maternal GWG category (adequate vs excessive) was reported 
for offspring adiposity measures. The authors reported that higher pre-pregnancy BMI was 
associated with higher child adiposity measures (BMI, WC, SAT and VAT) in all GWG 
category, but the effect was stronger in the excessive GWG group and reached significant level 
for child’s BMI, WC and SAT.   
The associations between GWG and childhood adiposity by anthropometric indicators 
were reported by two large studies. Ensenauer et al. [60] reported the results from a retrospective 
study of 6,837 mother-child dyads from Germany. Maternal GWG was categorized as 
inadequate, adequate or excessive, and the offspring BMI and waist circumference at 5.8 years 
were categorized as overweight (BMI > 90th percentile) and excessive abdominal adiposity (WC 
> 90 age and sex specific percentile), respectively.  In this study, 53.6% women gained 
excessively. Results showed that when compared to adequate maternal GWG, excessive GWG 
was related to both childhood overweight (OR 1.57) and abdominal adiposity (OR 1.39). 
Disparities were also found when examining within pre-pregnancy group differences. When 
comparing to offspring born to normal weight women that gained appropriately, offspring born 
to normal weight women that gained excessively had a greater likelihood to be overweight (OR 
1.29) and have excessive abdominal adiposity (OR 1.35). Similarly, offspring born to overweight 
14 
 
women that gained excessively were more likely to be overweight (OR 1.64) though no 
relationship to excessive abdominal adiposity was found.  
Dello Russo et al. [61] studied 12,775 mother-child pairs. The mothers were divided by 
GWG tertiles (interquartile range; tertile 1=8-11 kg, tertile 2=13-15 kg, tertile 3=18-24 kg), and 
anthropometric indices (waist circumference, subscapular and triceps skinfolds) of the children 
were measured at age 2-9 years.  ANCOVA found that all indices were increased across GWG 
tertiles.  Taken together, these studies clearly demonstrate that a significant association exists 
between maternal GWG and childhood adiposity.    
Studies have shown that the effect of GWG tracts into adulthood. However, only a few 
studies have measured body fat in adulthood using a more direct indicator than BMI such as 
skinfolds. The Motherwell Birth Cohort [51] reported on 276 mother-offspring pairs where the 
mothers had been enrolled during pregnancy from 1967-1968. When offspring were 27-30 years 
old, body composition was measured by skinfolds (biceps, triceps, subscapular and suprailiac). 
They found significant correlations between maternal GWG and offspring adult %FM (r=0.14, 
p=0.03) and FM index (r=0.14, p=0.03). Other studies used BMI as the proxy to measure body 
fat and similar trends were found. In a prospective study established in 1959–1961, 1,540 
offspring of mothers included in “The Copenhagen Perinatal Cohort” were followed from birth 
until 41 years old. The study found that GWG was associated with offspring BMI, and there was 
an increasing risk of offspring obesity (OR 1.08) per kg increase in GWG (p=0.003) [62]. 
Analysis of data from a study with cohort born in Brisbane between 1981-1983 showed an 
increase of offspring BMI by 0.3 kg/m2 for every 0.1 kg/week increase in maternal GWG [3]. 
The impact of excessive maternal GWG on offspring body composition and risk of obesity 
development tracks from birth to childhood and adulthood. These studies highlight the 
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importance for women to gain appropriate body weight during pregnancy for their given pre-
pregnancy BMI.  
 
2.2. Maternal adiposity and infant developmental outcomes 
While it is demonstrated that pre-pregnancy obesity and/or excessive GWG are associated 
with greater infant, child and adult adiposity, there is growing evidence to suggest that maternal 
pre-pregnancy obesity may impact infant cognitive function and development. Recent studies 
found that infants born to obese women are at increased risk of poor cognitive function and 
developmental disorders including lower cognitive development scores at 11-22 months [63], 
autism spectrum disorder and neurodevelopmental delay at 2-5 years of age [64], and attention 
deficit hyperactivity disorder at 7 years old [65]. In a study involving 30,212 women-children 
pairs, Huang et al. [66] reported that pre-pregnancy obesity was associated with lower offspring 
IQ at 7 years of age and this association was strengthened by controlling for maternal excessive 
GWG. Given the increasing prevalence of maternal obesity, and women gaining excessive 
GWG, these two maternal factors may contribute significant risk for cognitive problems in the 
offspring. 
Cognitive function is closely related to the autonomic nervous system (ANS). Studies 
showed that an alteration in the ANS can influence cognitive function and in conditions where 
the cognitive function is impaired, the ANS function is also decreased [67-71]. Next we will 




2.2.1. Overview of the autonomic nervous system 
The autonomic nervous system (ANS) regulates the body’s internal environment to 
achieve homeostasis. The system helps the body in the regulation of homeostatic mechanism 
(heart rate, circadian rhythm) and its malfunction is associated with of various diseases [72, 73]. 
In newborns, the system is particularly important for adaptation to the ex utero environment. 
The ANS consists of central and peripheral components. The peripheral ANS consists of 
sympathetic and parasympathetic nervous systems and is under control of central nervous system 
through the central autonomic network (CAN). The CAN is an integral component of the 
regulation system at the brain and the brain stem [74, 75]. The neurons of the ANS release 
neurotransmitters, with acetylcholine (Ach) and norepinephrine (NE) being the most common. 
Cholinergic fibers (nerve fibers that release Ach) include sympathetic and parasympathetic 
preganglionic fibers, all parasympathetic postganglionic fibers, and sympathetic postganglionic 
fibers of the sweat glands. Adrenergic fibers (nerve fibers that release NE) consist of mostly 
sympathetic postganglionic fibers [72].     
The first area of the ANS that develops in the human fetus is unmyelinated vagal fibers, 
which are part of parasympathetic nervous system, that arise from the dorsal motor nucleus 
(DMN) of vagus nerve (VN).  Immature DMN can be identified at 9 weeks of gestation in the 
brainstem and reach maturity at 28 weeks [76].  The myelinated vagal system which arises from 
the nucleus ambiguus (NA) develops last in the fetus.  The mature neurons appear as early as 8-9 
weeks gestation but the axons do not reach the cardiac tissue and do not show inhibitory effect 
until the myelination begins at the third trimester and continues to increase up to 1 year after 
birth [77]. The development of the sympathetic nervous system begins sometime between the 
development of the older DMN and the NA vagus. In accordance with the development of the 
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ANS, the fetal heart rate is primarily under the influence of sympathetic nervous system at early 
gestation and as the myelinated vagal system develops, the fetal heart rate decreases towards the 
end of gestation from 175 bpm at the first trimester to 140 bpm at term [78].   
The vagus nerve (VN) holds the physiological significance of the parasympathetic 
nervous system as it makes up 75% of all parasympathetic fibers. Myelinated fibers of the VN 
function as a vagal brake which inhibits the sinoatrial (SA) node, the heart pacemaker that 
regulates the heart rate. The high vagal tone inhibits the pacemaker and substantially decreases 
the heart rate. When the vagal tone is low, there is no or limited inhibition of the pacemaker and 
the heart rate will increase [79]. In contrast to parasympathetic influence, sympathetic action 
increases heart rate through its influence on the pacemaker and its innervation to the ventricular 
myocardium where it increases cardiac contractility. The sympathetic effect on the heart rate is 
much slower than the parasympathetic effects, and therefore, the changes in the heart beat to beat 
timing is mostly under parasympathetic influence [73]. Based on the influence of sympathetic 
and parasympathetic functions on heartbeat, analysis of the variability in the heart rate, therefore, 
can be used to assess the ANS function.  
 
2.2.2. Heart rate variability as indicator of the ANS 
Heart rate variability (HRV) is considered as a reliable indicator of the interplay between 
the sympathetic and parasympathetic systems [53, 80]. The cardiac cycle consists of contraction 
(systolic) and relaxation (diastolic) periods. The calculation of HRV indices are based on the 
time sequences of the beat to beat intervals. HRV analysis can be computed in linear domain, i.e. 
time- and frequency-domains, and non linear domain.  
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The time domain is an analysis of the continuous monitoring of cardiovascular 
parameters while the frequency domain is a spectral analysis that expresses heart rate oscillations 
[54]. The most commonly used components are: 1) standard deviation of normal sinus beat-to-
beat intervals (SDNN), expressed in milliseconds; and 2) Root mean square of successive 
difference between two consecutive inter beat intervals (RSMMD), also expressed in 
milliseconds and reflects parasympathetic activity [54]. On the other hand, the frequency domain 
is derived from the conversion of the time domain through a mathematical transformation called 
power spectral analysis. The spectrum consists of three components; a very low frequency (VLF) 
which is modulated predominantly by the sympathetic nervous systems, a low frequency (LF) 
band which reflects both sympathetic and parasympathetic activity [22], and a high frequency 
(HF) band which reflects parasympathetic activity [44]. In fetal HRV analysis, the frequency 
band cut offs are 0.02-0.08 Hz for VLF, 0.08-0.20 for LF, and 0.40-1.70 Hz for HF [81]. 
Respiratory Sinus Arrhythmia (RSA), the change in heart rate due to respiration, is another 
measure used in HRV analysis that reflexes parasympathetic activity.   
The non-linear domain includes several measures of HRV. One commonly used is the 
Poincaré plot.  Relative to other non linear methods, this method is simple to interpret.  It is a 
plot of the correlation between successive RR, that is, RRj+1 against RRj (Figure 1).  The plots 
make an ellipse shape that is oriented to the line-of-identity (RRj = RRj+1). The standard 
deviation of the plots that are perpendicular to the line (SD1) is closely related to the standard 
deviation of successive RR interval differences (RMSSD) and describes short-term HRV which 
is mainly affected by RSA.  On the other hand, the standard deviation of the plots along the line 
(SD2) is related to SDNN and SDSD and describes overall HRV [82, 83]. 
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Postnatal studies showed that the HRV is controlled by the central nervous system at the 
highest level (cerebral cortex) that transmits signals to the CAN at the nuclei in the brain stem 
and the spinal cord [84]. The output signals from the CAN is controlled at the nucleus solitary 
tract which is the site where the afferent vagus meet with efferent vagus [22]. The regulation of 
the vagal brake by myelinated vagal fibers is crucial for an individual to survive as it improves 
the ingestive vagal reflex during feeding, increases the capacity to self-regulate and calm, and the 
ability to develop social behavior [85].   
 
Figure 1. An example of Poincaré plot. The width (SD1) and length (SD2) of the ellipse are the 
standard deviation of the distance of the plots from each axis [82, 83].  
 
Fetal ANS function is measured by fetal HRV, which essentially reflects fetal cardiac 
autonomic control. As gestation develops, fetal HRV increases due to increased innervation of 
parasympathetic fibers into the heart and the influence of the autonomic control from the medulla 
oblongata to the cerebral cortex [27]. An anatomical study using human fetuses suggested that 
the critical period of brain development related to the fetal heart rate control is around 28-30 
week of gestation [86]. This is also the time period where fetal behavior states emerge.  
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There is evidence that individual differences in fetal HRV measured at the third trimester 
of pregnancy is conserved until the end of pregnancy and possibly after birth. Di Pietro et al. [27] 
measured fetal HRV of 137 fetuses of healthy mothers longitudinally from 20 to 38 week of 
pregnancy. They found little variation in individual HRV growth trajectory at 20-28 weeks and 
28-38 weeks, suggesting that those with lower or higher fetal HRV growth rates at earlier period 
tended to have lower or higher rates at the end of the pregnancy. Another study reported that 
higher fetal HRV is associated with higher HRV measured at 1 year of age [87].  
 A large body of evidence shows that higher HRV is associated with better cognitive 
function and development [70, 80, 88-90]. In developmental studies, HRV has been used as a 
physiological indicator of the child’s performance including information processing, 
development and cognitive assessment [68, 91-93].   
 
2.2.3. The association between HRV and cognitive and developmental outcomes  
Child developmental studies have shown that the fetal and neonatal HRV can predict the 
neurodevelopmental outcomes of a child. Fox et al. [91] used ECG to record the heart rate 
pattern in 80 full term neonates.  From the recording, they quantified RSA, one of the HRV 
components, using spectral analysis. At 8 and 12 month of age, Bayley scales were applied to 
assess developmental outcomes. They reported that all infants with high vagal tone, as indicated 
by high RSA, had positive developmental outcomes at both 8 and 12 month, while those with 
low vagal tone had varied results. In a study including very low birth weight pre-term infants, 
Doussard-Roosevelt et al. [94] measured various HRV components including RSA at birth and 
developmental outcomes at 3 years of age. They reported significant associations between higher 
RSA and better social and motor skills, and better mental processing. A similar trend was also 
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demonstrated in a study with normal healthy infants by DiPietro et al. [27]. In the study, fetal 
HRV measured at 28 weeks of gestation or later was shown to predict mental and psychomotor 
development as well as language ability of the infants at 2 years - 2.5 years of age.   
Collectively, these studies demonstrate that an association exists between the fetal HRV 
and cognitive function in infancy. The exact mechanism that underlies the association remains 
unclear; however, the fact that the ANS is closely related to cognitive function has been 
confirmed.   
2.2.4. The ANS and cognitive aspects interplay 
Two theories were proposed to explain the interaction between the ANS and the 
cognitive responses, i.e., polyvagal theory and neurovisceral integration theory [95, 96]. The 
polyvagal theory, introduced by Porges in 1995 [95], proposed that there are two distinct origins 
of vagal fibers, the NA and the DMN. Both pathways end at the SA node, the heart pacemaker, 
and contribute to the RSA; however, the NA, which is the primitive one, is thought to be 
dominant. On the other hand, the fibers from DMN are more evolved and linked to social 
interaction and self-behavior. The theory follows the phylogenetic hierarchy and suggests that 
the ANS develops according to the environmental challenge and responds accordingly. Thus, the 
theory emphasizes the role of physiological state in regulation of behavior and psychological 
responses. The neurovisceral integration theory, proposed by Thayer and Lane in 2000 [96], 
suggests an integration of the cognitive, behavioral and physiological factors regulations. The 
theory emphasizes the importance of the inhibitory mechanism by the CAN system to 
sympathetic responses through vagal activity.   
The association between the ANS and cognitive function is further confirmed by 
anatomical and physiological studies. Studies in animal models have identified neural pathways 
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that transmit visceral information to the cerebral cortex and identified sites in the cerebral cortex 
that regulate the autonomic response [97, 98]. In human studies using functional MRI, these 
specific sites in cerebral cortex have been identified and in addition to autonomic regulation, the 
sites were also shown to have significant roles in cognitive function [80, 84, 96]. These findings 
further highlight the close interaction between the ANS and cognitive function. 
The proper function of the ANS in young infants is reflected by their capacity to regulate 
their mental state, i.e. their behavior, in accordance with the environment challenges. The 
neonatal behavior assessment scale (NBAS), developed by T Berry Brazelton and his colleagues 
in 1973, is a method to assess self-regulation behavior in newborns and has been proven to 
predict developmental disabilities at later ages in low birth weight and premature infants [99]. In 
healthy infants, the method is also suggested to be useful to predict later development [27]. The 
scale includes behavioral items for optimal performance, reflex items for neurological function, 
and supplementary items that assess the general performance of the newborns [100].   
Taken together, the data suggest that the ANS is associated with cognitive function, and 
in young infants, it is an important predictor for cognitive function and development. The 
development of the ANS starts as early as 8 weeks in utero and maternal factors, particularly 
nutrition, have been shown to shape this process.     
 
2.2.5. Maternal nutritional factors and infant autonomic development 
In animal studies, maternal nutritional factors during pregnancy influence offspring 
nervous system development. The effect of refined carbohydrate intake on the fetal ANS was 
shown in a study by Young et al. [31]. Using a rodent model, the investigators observed an 
increase in NE content of the pancreas and retroperitoneal fat in the fetus of rats whose mothers 
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were fed diets high in refined carbohydrate, indicating activation of sympathetic system in those 
organs. A similar effect was shown with a high fat diet intervention. Prior et al. [101] reported an 
increase in renal sympathetic activity in 4 month old rabbit offspring whose mothers were fed a 
high fat diet.  In primates, offspring exposed to high fat diet during pregnancy showed alteration 
in their central serotonergic system as well as increased anxiety [102].  
Human studies showing the effect of maternal nutrition on fetal ANS development are 
limited.  DHA is one nutrient that has been studied and shown to impact fetal HRV. In a 
randomized controlled clinical trial by Gustafson et al. [81], pregnant women were supplemented 
with either 600 mg/day DHA or placebo starting at 14.4 (+4) week of pregnancy until delivery. 
The study found that offspring of the supplemented group had significantly higher fetal HRV 
than the control group as well as better scores on the NBAS in autonomic and motor behavior 
domains which reflect better cognitive function. Thus, the study demonstrated a direct effect of 
the intrauterine environment, that is, DHA intake, on fetal autonomic and cognitive development.  
While nutrition appears to be important for proper development of fetal ANS, maternal 
obesity, a state of over nutrition, is thought to negatively impact fetal ANS development. 
 
2.2.6. Maternal adiposity and infant autonomic development 
Maternal adiposity during pregnancy has been shown to influence cognitive function of 
the offspring in many studies [64-66, 103]. However, the effect of maternal adiposity on the fetal 
ANS, to our knowledge, has not been clearly demonstrated. A study by Ojala et al. [104] found a 
positive correlation between fetal cardiac sympathetic activity recorded by fetal 
electrocardiogram (ECG) during delivery to maternal pre-pregnancy BMI. This suggests that 
higher maternal adiposity is related to poor fetal autonomic function. However, the observed 
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autonomic response using this method was limited and therefore the complete feature of the fetal 
HRV could not be obtained.   
Although the evidence of an association between maternal obesity and fetal ANS 
alteration is limited, there have been biochemical and cellular studies that suggest such an 
association.  
 
2.3. Potential mechanisms by which maternal adiposity influences the fetal ANS 
The mechanism behind how maternal adiposity influences fetal ANS development 
remains largely unknown. Since excessive adipose tissue induces many hormonal and 
biochemical alterations, it is suggested that these changes, particularly inflammation and insulin 
resistance, mediate the observed fetal ANS and cognitive disturbances. 
 
2.3.1. Obesity induces insulin resistance and inflammation 
Excess adipose tissue found in obesity not only functions as a fat depot for energy storage 
but also acts as an active endocrine organ which releases various active substances that are 
collectively called adipocytokines [105]. As obesity develops, the adipose tissue is infiltrated by 
macrophages that releases inflammatory mediators and brings about a state of systemic low 
grade inflammation [106]. In contrast with adipose tissue in lean individuals which preferentially 
releases adipocytokines that are anti-inflammatory, adipose tissue in obesity secretes mainly pro-
inflammatory adipocytokines which can induce IR. Some common pro-inflammatory 
adipocytokines include Retinol Binding Protein (RBP4), Tumor Necrosis Factor-α (TNF-α), 
Interleukin-6 (IL-6), Monocyte Chemoattractant Protein-1 (MCP-1), and leptin [107]. 
In addition to the pro-inflammatory cytokines, free fatty acids (FFAs) released from 
adipose tissue also contribute to adipose induced inflammation and insulin resistance. The 
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increased release of FFA stimulates the adipose tissue macrophages to produce larger amounts of 
inflammatory mediators [108] while the elevated level of circulating FFA induces insulin 
resistance in various organs [109]. The great flux of plasma FFAs is followed by their uptake in 
myocytes, adipocytes, and hepatocytes where the FFAs and the fatty acids intermediates induce 
IR [110]. This obesity-induced inflammation and IR can further contribute to ANS dysfunction. 
 
2.3.2. Inflammation and insulin resistance induce ANS dysfunction 
In non-pregnant obese individuals, inflammation and IR induced by excess adipose tissue 
was shown to underlie autonomic dysfunction [11-14, 19, 20, 111-116]. Inflammatory 
adipocytokines released from adipose tissue directly stimulates the central sympathetic nervous 
system in the hypothalamus, or indirectly induces a low-grade inflammation state that stimulates 
sympathetic activation [117]. Obesity-induced IR results in elevation of plasma insulin, glucose, 
and glycation end products that can cause autonomic dysfunction. Moreover, insulin stimulates 
sympathetic excitation in the hypothalamus [118] and chronically elevated glucose levels were 
shown to induce parasympathetic loss [21], resulting in an autonomic imbalance. The effect of 
obesity-induced inflammation and insulin resistance on fetal ANS development in pregnancy, to 
our knowledge, has not been reported.  However, there is evidence that maternal adiposity causes 
inflammation and IR in the fetus. 
 
2.3.3. Maternal adiposity induces fetal inflammation and insulin resistance 
Data from animal studies show that changes in metabolism leading to inflammation and 
IR that are induced by excess adipose tissue observed in non-pregnant subjects were also 
observed in late pregnancy and considered physiologic [119-121]. These changes are more 
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prominent in an obese pregnancy and shown to induce inflammation and IR in the offspring. In a 
sheep model, fetuses of obese mothers have a lower number of pancreatic beta cells and lower 
insulin levels when compared to offspring born to lean mothers [122]. Also, the placental fatty 
acid transporter expression of the fetuses of obese mothers were increased as well as the cytokine 
expression [123]. Maternal adiposity, both prior to conception and gained during the gestational 
period, determined the level of maternal insulin sensitivity, and fetal size and adiposity [124]. 
Similarly, in a rat model a maternal high fat diet (HFD)-induced adiposity during 
pregnancy was shown to induce hyperleptinemia and IR of the fetus. In addition, fetal 
subcutaneous adipose tissue was hypertrophic with an increase in the levels of inflammatory 
cytokines but a decrease in the level of glucose transporter-4 mRNA [121, 125]. 
The influence of maternal pre-pregnancy adiposity on IR and inflammation of the 
offspring in human was first reported by Catalano et al. [126]. In a study involving 68 obese and 
53 lean pregnant women who went through an elective cesarean section, they found a positive 
association between maternal pre-pregnancy BMI and fetal adiposity and IR, and between fetal 
adiposity and fetal IR. Therefore, offspring born to obese mothers were fatter and more insulin 
resistant. Obese mothers had higher levels of leptin, IL-6, and CRP than did the lean mothers, 
while fetuses of obese mothers had higher leptin and CRP levels. The study demonstrated that 
obese pregnant women and their fetuses had higher levels of inflammation, and that the fetuses 
of obese mothers developed insulin resistance in utero.  
To test if maternal adiposity influenced inflammation in the fetus, Aye et al. [127] 
collected cord plasma following cesarean delivery and analyzed maternal and fetal pro-
inflammatory cytokines, and placental activation of inflammatory pathways. They found that 
higher maternal pre-pregnancy BMI was associated with higher maternal cytokines. Moreover, 
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they found that TNF-α appeared to induce activation of certain inflammatory pathways. The 
study suggested that maternal adiposity-induced inflammation alters placental function by 
activation of specific inflammatory pathways which further influences the fetal growth. 
 
2.3.4. Obesity induced-inflammation in pregnancy and offspring cognitive outcomes  
The role of obesity-induced inflammation during pregnancy on cognitive disruption of 
the offspring was demonstrated in animal studies. In HFD induced-obese pups, Bilbo et al. [128] 
observed inflammation in the brain as indicated by increase in microglial activation markers in 
the hippocampus at birth, and pro-inflammatory cytokine expression at weaning and adulthood, 
as well as anxiety and spatial learning changes. Similarly, Kang et al. [129] found that maternal 
diet-induced obesity resulted in brain inflammation of the offspring as marked by increased brain 
IL-1, TNF-α and microglial activation, as well as behavior deficits including anxiety, 
hyperactivity and decreased sociability. While studies have shown that the intrauterine 
environment, i.e. maternal adiposity, influences infant autonomic and cognitive outcomes 




The problem of maternal pre-pregnancy obesity and excessive GWG are high and still 
increasing.  This brings great concern as both conditions are known risk factors for various 
adverse health effects on both mother and infant. Maternal obesity and excessive GWG are 
associated with higher infant adiposity at birth, and a greater risk of obesity in childhood and 
adulthood. Recent findings suggested that maternal obesity is associated with poor infant 
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cognitive function and development. However, whether this is a direct effect of maternal 
adiposity or mediated through increased infant adiposity is yet to be elucidated. Cognitive 
function is closely related to the ANS and fetal HRV, an indicator of fetal ANS, has been used to 
predict the cognitive and developmental outcomes of the child. It is suggested that maternal 
obesity serves as an in utero factor that influences the fetal ANS, and that the alterations in 
cognitive function and development of the child seen after birth are shaped by the in utero 
environment. How maternal obesity can influence the fetal ANS is largely unknown, but it is 
suggested through maternal inflammation and insulin resistance induced by obesity during 











































This study included a total of 48 mother-fetus/newborn pairs from two observational 
studies, i.e. “Factors affecting growth pattern and body composition of infants (HSC#: 13126)” 
and “Developmental origin of fetal autonomic control (HSC#: 0312)”. Recruitment was 
conducted by approaching patients from the KUMC Obstetric and Gynecology clinic that were 
screened from the hospital O2 software system prior to their visit, and by sending study 
advertisement email blast to KUMC academic community.  
The inclusion criteria were 18-35 years of age and singleton pregnancy. Candidates were 
excluded if they have one or more of these conditions: 1). BMI<18.5 kg/m2, 2). twins, triplet or 
more, 3). gestational diabetes mellitus and 4). pre-existing chronic diseases that can influence 
fetal growth and or development.  Eligible candidates were enrolled at 20-30 weeks of 
pregnancy.     
 
3.2. Data collection 
3.2.1. Maternal pre-pregnancy BMI and GWG 
Pre-pregnancy weight was determined by pre-pregnancy self-reported body weight.  
Body height was measured using a wall stadiometer to the nearest cm. Maternal pre-pregnancy 
BMI was calculated by dividing pre-pregnancy body weight in kilogram by the square of body 
height in meters. GWG was calculated by subtracting self-reported highest body weight during 




3.2.2. Blood assay 
Blood was drawn from the subject’s vein and collected in a vacuum tube containing 
heparin after an overnight fast at 36 weeks of pregnancy. The heparin containing blood was 
centrifuged and the plasma was separated and stored at -80 C° in a liquid nitrogen tube until 
analysis. Plasma glucose level was analyzed by enzymatic colorimetric method (Cayman®). 
Analysis of plasma insulin (Alpco®), TNF-α (Quantikine, R&D®) and IL-6 (Ebioscience®) were 
conducted using ELISA method. Insulin resistance was determined by homeostasis model 
assessment (HOMA) calculated using the mathematical formula for approximate estimation 
[130]: 
HOMA index = (fasting blood insulin (μIU/mL)*fasting blood glucose) /22.5 
 
3.2.3. Infant body composition assessment  
Newborn FM was assessed using air displacement plethysmography (Pea Pod®) within 2 
– 5 days after delivery. Prior to the assessment, the baby’s clothing is removed including the 
diaper. A tight cap is put over the baby’s head to reduce the hair volume that might cause 
inaccuracy in the body volume measurement.   
Newborns were placed naked on a scale to measure body weight for 6-20 seconds and 
then placed in the Pea Pod chamber for 2 minutes to measure body volume. Body density was 
calculated from body weight and volume, and then converted to newborn FM using equations 




3.2.4. Fetal HRV assessment 
The fetal HRV tests were conducted at 32 and 36 weeks of gestation. Prior to the test, the 
subject was instructed to remove any metal such as underwire bra and jewelries. The test was 
conducted in a magnetically shielded room. The subject sat in the exam chair with her abdomen 
resting next to the fetal magnetocardiogram (MCG) surface with minimum pressure.  Magnetic 
signals from the abdomen were recorded by 83 axial gradiometer sensors that were spatially 
spread on the MCG surface. The data were recorded in 20 minutes using 500 Hz sampling rate 
and 0-75 Hz recording filter. The MCG recordings were presented to Kubios HRV Analysis 2.1 
software (University of Kuopio, Kuopio, Finland). Fetal MCG was separated from maternal 
MCG and artifacts, and the non-linear domain was analyzed using Poincaré plot method to 
calculate SD1 and SD2. The change in fetal HRV was defined as the difference in SD1 and SD2 
between those measured at 36 weeks and 32 weeks of gestation.           
 
3.2.5. NBAS 
The assessment of neonatal behavior was conducted by a certified psychologist using the 
NBAS within 1-5 days after delivery. The scale consists of 7 clusters developed by Lester et al. 
1984 [132], including habituation, orientation, motor, range of state, regulation of state, 
autonomic stability and reflexes.  The total score for each cluster is the sum of the item scores 
under the corresponding cluster.  The score of the items range from 0-9 with higher scores reflect 
better performance except for those under reflexes cluster. The reflex clusters scored 0-4 with 




3.3. Statistical analysis 
Descriptive statistics for maternal and offspring variables were calculated as means and 
standard deviations.  The associations between outcome and predictor were analyzed using 
bivariate correlations. For aim 1, bivariate correlations were analyzed between 3 predictor 
variables of interest (pre-pregnancy BMI, GWG, and newborn FM) x 5 outcomes (SD1, SD2, 
SD1 change, SD2 change, and NBAS scores). For aim 2, bivariate correlations were analyzed 
between 3 predictor variables of interest (maternal HOMA index, TNF-α and IL-6) x 4 outcomes 
(SD1, SD2, SD1 change, and SD2 change). 
Predictor variables with significant associations and the highest coefficient of 
determination (R2) were included in multiple regression analysis for each outcome variable. The 
following potential confounding variables were explored in the models: maternal pre-pregnancy 
BMI, infant gender and neonatal age (for models with NBAS score outcome only).    
Pair-wise correlation coefficients among independent variables were assessed to identify 
collinearity. Level of significance is set at α =0.05. Logarithmic transformation of data was 
planned to normalize the distribution if necessary. Statistical analyses was performed using IBM 


































A total of 80 women participated in the study. However, a complete dataset was not 
available for all participants. The following list includes the number of samples collected for 
each outcome: fetal HRV at 32 weeks was collected in 30 women, fetal HRV at 36 weeks was 
collected in 48 women, data on blood analysis were available from 44 subjects, and data on 
infant body composition was available from 42 newborns (Figure 2). The levels of maternal 
TNF-α in 3 subjects were not detectable and therefore were excluded from the analysis leaving 
n=41 viable samples. The NBAS assessments were conducted in 20 newborns. However, due to 
an unsuitable newborn alert state when the test was performed, only data from 6 and 7 newborns 
were valid for habituation and orientation clusters, respectively. For other NBAS clusters, data 
from 13 newborns were available.  
 
4.1. Subject characteristics 
Descriptive statistics for maternal and offspring variables are listed in Table 1. Most 
women were Caucasian (83.33%), and the rest were African American (8.33%), Hispanic and 
Asian (4.17% each). The average pre-pregnancy BMI was 27.16 kg/m2. About half of the women 
(47.9%) had a normal pre-pregnancy BMI, while 18.7% and 33.3% were overweight and obese, 
respectively. The average GWG was 15.61 kg. Based on the 2009 IOM GWG guidelines, 54.2% 
and 39.6% of women gained excessively and adequately, respectively, and 6.2% gained 
inadequately. Forty eight percent of the newborns were male, and the average birthweight was 
















































Figure 2. Consort diagram 
 
30 subjects in GWG 
(HSC#0312) 
30 fetal HRV at 32 wk data were available 
65 subjects in THR 
(HSC#13126) 
33 completed fetal HRV at 36 wk 30 completed fetal HRV at 36 wk  
48 fetal HRV data at 36 wk were available 
 
44 blood analysis data at 36 wk 
were available  
 
42 Peapod data were available 
 
20 NBAS were performed  
 
2 were not consented for blood collection 
2 invalid measurements 
 
3 lost contact 
2 were dropped out 
1 invalid data  
18 were enrolled in THR 
only, not consented for 
NBAS. 
10 missed the NBAS 
 
 
7 were invalid  
 
15 were co-enrolled 





Table 1. Characteristics of subjects 
Characteristics Values* 
Mother (n=48)  
Race  
Caucasian  40 (83.33) 
African 4 (8.33) 
Hispanic 2 (4.17) 
Asian 2 (4.17) 
Age (year) 28.96 ± 3.20 
Family income ($/year) 60,430 (41,021-80,547.25)  
GA of delivery (week) 39.4 ± 0.9 
Pre-pregnancy BMI 27.16 ± 6.35 
Pre-pregnancy BMI category  
Normal (18.5-24.9) 23 (47.9) 
Overweight (25-29.9) 9 (18.8) 
Obese (>30) 16 (32.7) 
GWG (kg) 15.61 ± 6.04 
GWG category (IOM 2009)  
Inadequate  3 (6.25) 
Adequate  19 (39.6) 
Excessive  26 (54.2) 
Blood biomarkers (n=44)  
Glucose level (mg/dL) 93.6 ± 22.55 
Insulin level  (µIU/mL) 6.00 (3.43-8.10) 
HOMA-IR index 1.84 (0.74-1.93) 
IL-6 level 1.18 (0.95-1.49) 
TNF-α level (pg/mL), n=41 1.31 (0.56-2.75) 
Newborns (n=42)  
Male 23 (48) 
Birthweight (kg)  3.454 ± 0.40 
Body composition  
Age at assessment (day) 3.7 ± 3.9 
Body Mass (kg) 3.302 ± 0.377 
%Fat Mass (%) 11.7 ± 3.4 
Fat Free Mass (kg) 2.910 ± 0.299 
F-HRV   
36 wks, n=48  
SD1 (msec) 4.39 ± 1.91 
SD2 (msec) 32.66 ± 10.97 
32 wks, n=30  
SD1 (msec) 3.21 ± 0.83 
SD2 (msec) 27.62 ± 10.91 
NBAS scores  
Habituation (n=6) 21.7 ± 2.4 
Orientation (n=6) 34.1 ± 9.5 
Motoric (n=13) 25.7 ± 4.4 
State organization (n=13) 13.5 ± 2.9 
State regulation (n=13) 16.7 ± 4.2 
Autonomic (n=13) 17.2 ± 2.7 
Reflexes (n=13) 2.3 ± 1.6 
*values are n (%), mean + SD, or median (Q1-Q3) 
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4.2. Maternal and newborn factors to predict fetal HRV 
Bivariate correlations between fetal HRV measures and maternal and newborn factors are 
listed in Table 2. Greater GWG was associated with a greater SD1 and a greater SD1 change 
(r=0.42; p=0.003 and r=0.48; p=0.008, respectively). These associations were further tested by 
multiple linear regression models to determine if correlations between GWG and fetal HRV 
remained significant while controlling for pre-pregnancy BMI and infant gender. We found that 
pre-pregnancy BMI and infant gender were not correlated to either SD1 or SD1 change. When 
controlling for pre-pregnancy BMI and infant gender, the positive associations between GWG 
and SD1 as well as between GWG and SD1 change remained significant (Table 3). Correlations 
between GWG and SD1 and SD1 change were also assessed within pre-pregnancy BMI category 
(normal and overweight/obese). GWG was significantly associated SD1 (Figure 3B) and SD1 
change (Figure 4B) within overweight/obese group, but not within normal group.  
The negative relationship between maternal TNF-α and fetal SD2 approached 
significance (r=-0.29, p=0.07). Similarly, the negative relationship between newborn %FM and 
fetal SD2 change approached significance (r=-0.29, p=0.061). A negative correlation was found 
between newborn %FM and SD2 change (r=-0.41, p=0.040). However, when performing 
multiple linear regression and adjusting for maternal pre-pregnancy BMI and infant gender, the 
correlation weakened (β=-1.2, p=0.055). Correlations between newborn %FM and fetal SD2 
change was also assessed within pre-pregnancy BMI category (normal and overweight/obese). 
The significant inverse association between newborn %FM and fetal SD2 change was observed 
within overweight/obese group, but not within normal group (Figure 5).  
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We found no significant association between any of the fetal HRV measures and pre-
pregnancy BMI, maternal HOMA-IR, maternal IL-6 level, newborn FFM and newborn BM 
(Table 2).  
 
4.3. Maternal and newborn factors to predict newborn neurobehavior 
Using Spearman’s correlation analysis, we found no significant correlations between the 
NBAS cluster scores and maternal factors as well as newborn factors (Table 4). However, two 
correlations approached significance: GWG and newborn state of organization (r=-0.53; 
p=0.065) and newborn BM and newborn orientation (r=0.75; p=0.052). The characteristics of 
subjects with NBAS data are listed in Table 5. 
 
Table 2. Pearson correlations between fetal HRV components their predictors 
Predictors 
Fetal HRVa 
SD1 SD2 SD1 change SD2 change 
Pre-pregnancy 
BMI 
-0.003 (-0.300-0.294) -0.055 (-0.351-0.241) 0.141 (-0.247-0.530) -0.022 (-0.415-0.369) 
n 48 48 30 30 
     
GWG  0.420** (0.151-0.689) 0.220 (-0.070-0.510) 0.481**(0.137-0.826) 0.040 (-0.350-0.432) 
n 48 48 30 30 
     
HOMA-IR -0.257 (-0.573-0.059) -0.186 (-0.502-0.125) -0.069 (-0.429-0.290) -0.047 (-0.403-0.309) 
n 43 43 27 27 
     
IL-6 0.174 (-0.140-0.489) 0.089 (-0.222-0.400) 0.266 (-0.103-0.551) 0.114 (-0.220-0.447) 
n 44 44 28 28 
     
TNF-α -0.034 (-0.378-0.309) -0.285 (-0.617-0.026) -0.232 (-0.693-0.229) -0.016 (-0.463-0.432) 
n 41 41 27 27 
     
%FM -0.208 (-0.531-0.114) -0.294 (-0.601-0.014) -0.086 (-0.535-0.364) -0.343*(-0.669- -0.018) 
n 42 42 25 25 
     
FFM 0.156 (-0.170-0.481) 0.241 (-0.072-0.553) 0.151 (-0.293-0.595) -0.013 (-0.368-0.343) 
 n 42 42 25 25 
     
BM 0.072 (-0.256-0.401) 0.117 (-0.202-0.437) 0.097 (-0.324-0.518) -0.119 (-0.450-0.212) 
n 42 42 25 25 
a Values are correlation coefficient (confidence interval) 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
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Table 3. Multiple linear regressions to predict fetal HRV measures 
Independent N Dependent β (CI) p-value R2 
GWG 48 SD1 0.442 (0.161-0.724) 0.003 0.19 
Pre-pregnancy BMI    0.088 (-0.200-0.377) 0.540  
Infant gender   -0.033 (-0.315-0.249) 0.813  
      
GWG 30 SD1 change  0.511 (0.155-0.867) 0.007 0.27 
Pre-pregnancy BMI    0.198 (-0.157-0.554) 0.262  
Infant gender   0.077 (-0.293-0.447) 0.672  
      
Newborn %FM 25 SD2 change -0.426 (-0.715-0.009) 0.055 0.17 
Pre-pregnancy BMI    0.023 (-0.354-0.394) 0.914  
Infant gender   0.034 (-0.349-0.410) 0.869  
 
Table 4. Spearman’s correlations NBAS cluster scores and maternal and newborn adiposity 
Predictors 






(n=6) (n=7) (n=13) (n=13) (n=13) (n=13) (n=13) 
Maternal         
Pre-pregnancy BMI -0.03 -0.11 -0.36 0.01 0.17 -0.07 -0.01 
GWG 0.20 0.36 0.21 -0.53* 0.12 0.00 -0.18 
Newborn         
%FM 0.61 0.46 0.14 -0.37 -0.04 -0.40 -0.21 
FFM 0.52 0.61 0.26 0.41 -0.25 -0.08 0.05 
BM 0.52 0.75** 0.25 0.29 -0.33 -0.18 0.06 
*p = 0.065 
**p = 0.052 
 
Table 5. Characteristics of the 13 subjects with NBAS data   
Characteristics Mean ± SD/Q2(Q1-Q3)/n 
Mother   
Age (year) 27.23 ± 3.52 
Family income ($/year) 45,977.5 (35,212.5-53,454.5)  
  
Pre-pregnancy BMI 24.67 ± 4.23 
Pre-pregnancy BMI category  
Normal (18.5-24.9) 8 
Overweight (25-29.9) 3 
Obese (>30) 2 
GWG (kg) 16.84 ± 6.11 
GWG category (IOM 2009)  
Inadequate  0 
Adequate  6 
Excessive  7 
Newborns  
Male 4 






























Figure 3. Relationship of fetal HRV (SD1) at 36 week of gestational age and gestational weight gain in women with: 












Figure 4. Relationship of fetal HRV difference between 36 and 32 week of gestational age (SD1 change) and 
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Figure 5. Relationship of fetal HRV difference between 36 and 32 week of gestational age (SD2 change) and 
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Neurodevelopment during the gestational period and in early life is critical to program 
offspring long-term cognitive performance, social skill, language, and motor function. In the 
present study, we asked whether fetal exposure to maternal obesity impacts in utero offspring 
autonomic nervous system development or infant behavior early in the postnatal period.  We also 
asked if maternal inflammation and IR were associated with fetal autonomic nervous system 
development. We assessed if fetal HRV, a proxy of fetal autonomic nervous system, is predicted 
by maternal and infant adiposity, and maternal IR and inflammation. We found that greater 
GWG was associated with greater short-term variability of fetal HRV (SD1) and the change in 
fetal HRV from 32-36 weeks of gestation. These relationships remained significant after 
controlling for the effect of maternal pre-pregnancy BMI and infant gender. Greater newborn 
%FM was associated with lower change in overall variability of fetal HRV (SD2), but the 
association was diminished after adjusting for pre-pregnancy BMI and offspring gender. Infant 
behavior was assessed using NBAS. However, we found no correlation between any of NBAS 
cluster scores and maternal or infant predictors. Thus, we found that fetal HRV measures were 
positively associated with maternal adiposity but negatively associated with infant adiposity. We 
found no evidence of an association between fetal HRV and maternal IR nor maternal 
inflammation state during pregnancy.   
 
5.1. Maternal pre-pregnancy BMI and offspring neurodevelopment  
Maternal pre-pregnancy BMI is inversely associated with child and infant 
neurodevelopmental outcomes in many large studies [103, 133-136]. For example, Jo et al. [134] 
measured offspring development at 6 years of age in 1,311 mother-child pairs and reported 
increased risks for having emotional symptoms, peer problems, psychosocial difficulties, and 
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other developmental problems for children born to severely obese women. Similar results were 
reported in a study by Hinkle et al. [133] which analyzed data on mental developmental index 
(MDI) and psychomotor development index (PDI) of 6,850 children at 2 years of age. Children 
born to women with a very high maternal pre-pregnancy BMI (obese class II and III) had 
reduced MDI compared to those of normal pre-pregnancy BMI. Casas et al. [103] assessed 
cognitive development scores in a total of 2,379 infants aged 11-22 months from two birth 
cohorts and found an inverse association between maternal pre-pregnancy obesity (BMI >30 
kg/m2) and infant cognitive development. 
Although maternal pre-pregnancy BMI is inversely associated to offspring 
neurodevelopment outcomes, there is inconsistent evidence when studies are replicated in other 
cohorts or when confounding factors (i.e. family education and socio-economic status) are 
considered [137, 138]. To determine if the relationships were driven by intrauterine factors, the 
assessment of the outcomes needs to be performed in perinatal period i.e. in fetuses or newborns. 
To our knowledge, studies investigating the relationship in newborns have never been reported. 
We attempted to study such relationships by examining newborn behavior as a proxy for 
newborn neurodevelopment using NBAS. We did not find any significant associations between 
maternal adiposity and any of the NBAS cluster scores. However, since our sample was reduced 
due to technical problems, our small sample size may have reduced our ability to detect 
relationships. The relationship between maternal adiposity and offspring autonomic nervous 
development measured in fetuses was investigated in two studies [104, 139] and are discussed 





5.2. Maternal pre-pregnancy BMI and fetal HRV 
Though many studies have investigated the relationship between maternal adiposity and 
offspring neurodevelopment in childhood, only two studies [104, 139], to our knowledge, have 
investigated the relationship in fetuses. Fetal HRV, an index of cardiac autonomic control, was 
used as a proxy for fetal neurodevelopment. In theory, greater HRV reflects more mature 
autonomic control and potentially better fetal neurodevelopment. In agreement to studies 
conducted in infants and children, the two studies by Voegtline et al. [139] and Ojala et al. [104] 
reported an inverse relationship between maternal pre-pregnancy BMI and fetal HRV. In 
Voegtline et al. [139] study, pregnant women were grouped based on their pre-pregnancy BMI 
into normal weight (n=382), overweight (n=129), or obese (n=67). Fetal autonomic nervous 
system development was indicated by overall fetal HRV and the data were recorded using fetal 
actocardiograph. At 36 weeks of pregnancy, fetal HRV of the obese group was significantly 
lower than the normal group (p=0.024). In the other study, Ojala et al. [104] analyzed fetal HRV 
in 41 fetuses of normal pregnancies (pre-pregnancy BMI ranged from 18.2 to 34.9 kg/m2) using 
fetal ECG during delivery. A positive association was found between maternal pre-pregnancy 
BMI and the LF/HF ratio, a measure of autonomic balance (r=0.3, p<0.05). While overall fetal 
HRV is a reflection of both sympathetic and parasympathetic nervous system, the high LF/HF 
ratio indicates increased sympathetic activity or decreased parasympathetic drive. Hence, both 
Voegtline et al. [139] and Ojala et al. [104] studies showed that greater pre-pregnancy BMI is 
associated with reduced function of fetal autonomic nervous system.  
Our results were different from the studies of Voegtline et al. [139], Ojala et al. [104] and 
others conducted in infancy or beyond [103, 133-135]. We did not find a relationship between 
pre-pregnancy BMI and fetal HRV. The different results were unexpected since women in our 
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study and the studies by Voegtline et al. [139] and Ojala et al. [104] were similar in some 
respects; they were not underweight and were healthy. Some women in Voegtline et al. [139] 
developed gestational diabetes, but the trend of the results did not change when these women 
were excluded from the analysis. Compared to our study, the Voegtline et al. [139] study had a 
considerably larger sample size (578 vs 48) and therefore was more sensitive to detect 
differences. Ojala et al. [104] had a similar sample size as our study (n=41), but the study was 
focused on fetal sympathetic activity which is predictive for future cardiovascular diseases risk. 
Therefore, the fetal HRV components measured in their study (LF/HF ratio) did not sufficiently 
indicate the overall function of the fetal autonomic nervous system. Compared to both studies, 
we used a more sensitive and accurate method to assess fetal HRV. We also provided a more 
complete description of fetal HRV by measuring short-term and overall HRV.  
Our unexpected results might be due to maternal factors that were not controlled in the 
study. Outside of maternal adiposity, other maternal factors have been related to fetal HRV. 
Maternal intake of certain nutrients including Zinc [140-142] and DHA [81] and maternal 
physical activity level [143] during pregnancy were reported to influence fetal HRV. Although 
maternal excessive adiposity before pregnancy has been proposed to influence offspring 
neurodevelopment, the mechanism remains unknown. Beside the studies of Voegtline et al. 
[139], Ojala et al. [104], and ours, we are not aware of other studies investigating the relationship 
between maternal adiposity and fetal neurodevelopment. Thus, the programing effect of maternal 




5.3. Maternal GWG and offspring neurodevelopmental outcomes 
 We found that greater GWG was associated with better fetal HRV. Our finding was in 
accordance with studies that investigated the association in children [136, 138]. Gage et al. [136] 
analyzed data from Avon Longitudinal study cohort. The outcomes measured were school entry 
assessment (SEA) score at age of 4 years (n=5,832), intelligent quotient (IQ) at 8 years old 
(n=5,191) and school final-exam score at age 16 years (n=7,339). Analysis was controlled for 
confounders including maternal age, pre-pregnancy BMI, smoking status during pregnancy, 
parity, mode of delivery, maternal education gestational age, offspring’s age at outcome 
assessment, and offspring gender. Gestational weight gain in early (0-18 weeks), mid (18-28 
weeks), and late pregnancy (28 weeks – delivery) were positively associated with IQ, while 
GWG in early and mid-pregnancy was positively associated with SEA scores. Since a significant 
interaction was found between pre-pregnancy overweight/obesity and GWG regarding final-
exam score, the associations between GWG and the final-exam score were tested within each 
pre-pregnancy BMI category. In normal pre-pregnancy BMI, greater GWG at early pregnancy 
was associated with decreased odds of adequate final-exam score. However, in overweight and 
obese pre-pregnancy BMI, greater GWG in late pregnancy was associated with increased odds of 
adequate final-exam score. Thus, the study found that greater GWG was associated with better 
offspring developmental outcomes. In addition, the study also suggested that the relationship 
between GWG and offspring neurodevelopment differs based on pre-pregnancy BMI category, 
gestational period, and the type of neurodevelopmental aspect being measured.      
Another study investigating GWG and child neurodevelopment was conducted by Keim 
et al. [138] which included over 30,000 individuals who participated in the U.S. Collaborative 
Perinatal Project. Similar to the Gage et al. [136] study, Keim et al. [138] study suggested a 
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positive association. Children were assessed for cognitive development at 4 years of age by 
Stanford-Binet Intelligent Scale and Block sort test, and at 7 years of age by the wide range 
achievement test (WRAT) and the Weschler Intelligence Scales for Children (WISC). Multiple 
regression with general estimating equation (GEE) and fixed-effects (FE) models were used. In 
FE models, in addition to potential confounders that are controlled in GEE model (pre-pregnancy 
BMI, race, maternal age, smoking, parity, and socio-economic status), confounding factors 
shared in siblings, i.e. proportion of genetic factors and parenting practices, were also controlled. 
In GEE models, they found U-shaped associations between GWG and most of the cognitive 
outcomes. However, the associations were diminished when FE was applied. Using FE model, 
higher GWG was linearly associated with better scores in WRAT spelling (β=0.15, 95% CI: 
0.01-0.29) and WRAT arithmetic (β=0.15, CI: 0.02-0.28).  
In accordance with our findings, both Gage et al. [136] and Keim et al. [138]  studies 
suggested a positive association between GWG and offspring neurodevelopment. However, it is 
important to note that apparently, the association shown in each of the studies applied to a range 
of GWG that was less than that in our study. Women in our study gained more than those in 
Keim et al. [138] study (mean GWG 15.6 kg vs 10.1 kg). Also, the proportion of women who 
gained inadequately in Keim et al. [138] study was much greater than in our study (58% vs 
6.25%).  Gestational weight gain in Gage et al. [136] study was presented by gestational period 
and therefore we do not know the amount of their total GWG. However, from the amount of 
GWG by gestational period, we estimated that women in their study also gained less than those 
in our study. Similarly, the proportion of women who gained inadequately in Gage et al. [136] 
study was greater than that in our study (34% vs 6.25%). 
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Another study has found GWG both too low and too high are related to poor offspring 
neurodevelopment outcomes measured in childhood [144]. In the Tavris et al. [144] study, a total 
of 2,590 mother-child pairs participated in the Child Health and Development Studies at 
University of California, Berkeley [144]. Women were grouped based on their GWG into <5 lbs, 
5 to 29 lbs, and >29 lbs, and the child development outcome measured was Raven colored 
progressive matrices test at age 5 years. Children born to mothers who gained between 5 to 29 
lbs during pregnancy had a better score on the test compared to children of mothers from the 
other two groups. However, the analysis did not control for pre-pregnancy BMI.  Our study 
findings are in contrary to these findings. While Tavris et al. [144] found that children born to 
women who gained more than 29 lbs had reduced developmental test scores, we found that 
offspring exposed to excessive GWG had better fetal neurodevelopment. This is interesting 
considering women in our study gained a greater amount of weight than those in the Tavris et al. 
study [144]; our women gained between 12.5 to 70 lbs. The inconsistent findings among our 
study and others might be due to variations in subject characteristics especially the range of pre-
pregnancy BMI and GWG, offspring age, and methods used to assess the neurodevelopmental 
outcome.  
Data suggest that inadequate or excessive GWG is related to offspring neurodevelopment 
outcomes. To further investigate this finding, studies have used the 2009 IOM guidelines [145] 
to examine the relationship between appropriate versus excessive GWG and offspring 
developmental outcomes. However, study results are inconclusive. Gage et al. [136] reported that 
compared to children exposed to women with adequate GWG, children exposed to inadequate 
and excessive GWG had lower scores in school final-exam. Different results were reported in 
Keim et al. [138] study. In women who gained excessively, Keim et al. [138] found a positive 
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linear association between GWG and offspring WRAT scores at 7 years of age (β=1.41, CI: 
0.13-2.70). Our study was not designed to analyze the difference in offspring neurodevelopment 
by GWG recommendation classification, therefore we cannot compare our results with these 
findings.  
In overweight and obese women, greater GWG is associated with greater gains in 
maternal fat mass [146-148]. Therefore, we expected that both pre-pregnancy BMI and GWG 
would be inversely correlated with fetal HRV. Excessive fat mass accumulation, both before and 
gained during pregnancy, lead to maternal and fetal metabolic disturbances and consequently, 
results in various adverse pregnancy and offspring health outcomes [8]. We excluded women 
who were underweight before the pregnancy and almost all women in our study gained either 
adequately or excessively. Instead of an inverse association, we found a significant positive 
association between GWG and fetal HRV. As in the case of pre-pregnancy BMI, our unexpected 
result might be due to maternal factors that were not controlled in the study such as maternal diet 
[81, 140-142] and physical activity level [143].   
Our data and others suggest that maternal adiposity is an important predictor for offspring 
neurodevelopmental outcomes. Even so, the exact mechanism connecting how maternal 
adiposity may shape offspring neurodevelopment is unknown. Studies that investigate the 
association between maternal adiposity and fetal HRV are still limited and therefore more studies 
are needed to decipher the mechanism.  In addition, although fetal HRV is a considered as an 
indicator of fetal neurodevelopment [149], the evidence that it is predictive for post-natal 
neurodevelopment is limited [27, 92].  Our results therefore must be interpreted with caution, 
and we are not able yet to conclude that greater GWG is related to better offspring autonomic 
and neurocognitive function.    
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5.4. Newborn Fat Mass and Fetal HRV 
Our study found a negative association between newborn %FM and overall fetal HRV. 
The finding is in agreement with other studies that investigated the association in children and 
the elderly [13, 14, 150-152]. For instance, Vanderlei et al. [151] analyzed HRV of 121 children 
aged 8 to 12 years. Children in the obese group had significantly lower HRV in metrics that 
capture both sympathetic and parasympathetic function, suggesting a generalized decrease in 
autonomic control, when compared to those in normal-weight group.  
Although the inverse association between offspring adiposity measures and HRV have 
been demonstrated in a number of studies [14, 150, 153, 154], our study is the first to show the 
association in newborns and therefore suggests an in utero programming effect on infant 
autonomic nervous system development. Increased maternal adiposity is associated with 
increased infant adiposity [2, 5, 9, 48], and therefore our study also implies that increased infant 
adiposity might be mediating the relationship between maternal obesity and impaired offspring 
neurodevelopment demonstrated in numerous clinical studies [103, 133-135, 155, 156].  
 
5.5. Maternal insulin resistance and fetal HRV 
Maternal obesity, particularly pre-pregnancy overweight/obesity, is correlated with 
insulin resistance and inflammation in both the mother and fetus [119, 126, 127, 157]. In 
addition to their role in predisposing the fetus to develop obesity and metabolic disorders [2, 158, 
159], recent studies suggest that maternal insulin resistance and inflammation also play 
important roles in the mechanism by which maternal adiposity impacts fetal nervous system 
development [128, 160-163]. Insulin resistance, as in the case of maternal diabetes, was 
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associated with increased risk of cognitive and developmental problems in the children [160, 
163].  
Our results, however, did not support that maternal insulin resistance influences fetal 
autonomic nervous system control. Insulin is known as one of the key regulators for 
neurodevelopment, and the disruption of insulin regulation in the hippocampus by maternal 
diabetes was suggested to underlie the cognitive and memory deficit of children born to diabetic 
mothers [161]. The lack of association in our study might be due to the relatively lower degree of 
insulin resistance in our subjects as we excluded women with diabetes mellitus. Yet the 
association of diabetes during pregnancy and fetal HRV, to our knowledge, has never been 
demonstrated.  
 
5.6. Maternal inflammation and fetal HRV 
Maternal obesity induces both maternal and fetal inflammation which in turn results in 
neurodevelopment disturbances in early childhood and later in life [128, 162]. Increased levels of 
inflammatory cytokines in fetal circulation and amniotic fluid induced fetal brain inflammation 
and consequently, impaired neurocognitive and development function [164]. The increase in 
maternal inflammation, however, is not always followed by increased fetal inflammation as 
reported by Aye et al. [127]. In a study involving 60 women who had a cesarean section, 
maternal and fetal cytokines (IL-1β, IL-6, IL-8, MCP 1 and TNF-α) as well as inflammatory 
pathway activation in the placenta were investigated. They found that maternal pre-pregnancy 
BMI was associated with increased maternal cytokines and activation of certain placental 
inflammatory pathways, but the fetal inflammatory profile was not affected.  
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To our knowledge, our group is the first to report the associations between maternal 
inflammation and fetal HRV. We did not find evidence for a significant relationship between 
maternal levels of inflammatory cytokines (IL-6 and TNF-α) and fetal HRV. As in the case of 
IR, our subjects were relatively healthy and we did not find increased inflammatory cytokines 
levels with increased pre-pregnancy BMI or GWG (data not shown).    
 
5.7. Study limitations 
Our study used sophisticated methods to measure fetal autonomic nervous system 
development and infant body composition. However, our study also had some limitations. First, 
our sample size was small and might not be large enough to show significant associations, 
particularly for those involving the blood biomarkers. Second, we did not measure maternal body 
composition to measure body fat, and used self-reported pre-pregnancy body weight to calculate 
BMI. Third, we used only IL-6 and TNF-α among many cytokines to indicate the inflammation 
status while the true mechanism might involve other types of cytokine. Last, HRV metrics for 
fetus have not yet been established and so we applied adult HRV metrics which might not be 
suitable for the developing fetus. 
 
5.8. Conclusion 
In summary, based on our data we found that maternal and infant adiposity was 
associated with fetal autonomic nervous system control. Further, the impact of GWG and 
maternal pre-pregnancy BMI might have different pathways to exert their impact on the fetal 
HRV. Even though our study suggested that greater GWG was associated with better fetal HRV, 
the result has to be taken carefully due to the study limitations. The development of nervous 
system in utero is a complex process that is influenced by many factors not measured in this 
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study such as maternal diet, physical activity, oxidative stress, and body composition. Further 
studies with a larger sample size, better measures of maternal body composition, and studies that 
control for possible confounding factors are needed to provide comprehensive knowledge on 
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